Company Monitoring Page for Sandoz

latest headlines for company on cafepharma

Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Tags:
Sandoz, generics, biosimilars, Eylea, Novartis, wet age-related macular degeneration
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars, Humira, AbbVie, rebates, drug pricing, Amgen, Celltrion, Novartis, Boehringer Ingelheim, Biocon, Fresenius, Sandoz, Organon, Coherus
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
Tags:
AbbVie, Humira, biosimilars, Boehringer Ingelheim, Organon, Samsung Bioepsis, Sandoz, Fresenius Kabi, Celltrion, Coherus Biosciences, Biocon
Sanofi blocks Sandoz's Jevtana generic in patent win
Fierce Pharma
Fri, 06/30/23 - 10:16 am
Tags:
Sanofi, Jevtana, generics, Sandoz, prostate cancer, legal
Sandoz targets barriers to biosimilar accessibility with latest initiative
Pharmaceutical Technology
Thu, 06/15/23 - 07:00 pm
Tags:
Sandoz, Novartis, patient access, biosimilars
Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years
Fierce Pharma
Thu, 06/8/23 - 09:29 pm
Tags:
Novartis, Sandoz, generics, biosimilars
Novartis brings on 8 business vets for Sandoz's new board, including 4 women
Fierce Pharma
Tue, 05/16/23 - 12:12 pm
Tags:
Novartis, Sandoz, biosimilars, generics, women executives
Sandoz taps Evotec in long-term biosimilar development and manufacturing deal
Fierce Pharma
Wed, 05/10/23 - 10:00 am
Tags:
Novartis, Sandoz, Evotec, biosimilars
Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold
Fierce Pharma
Thu, 05/4/23 - 09:00 pm
Tags:
Novartis, Sandoz, generics, Adalvo
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Wed, 05/3/23 - 10:41 pm
Tags:
Amgen, Sandoz, legal, Prolia, Xgeva, patents, denosumab
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028
Fierce Pharma
Thu, 04/20/23 - 11:47 am
Tags:
Amgen, Otezla, immunology, generics, Sandoz, Zydus, patents
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says
Endpoints
Mon, 04/3/23 - 10:46 pm
Tags:
Sandoz, Allergan, Duke University, legal, patents, Latisse
Sandoz, betting on biosimilar sales, to build new production plant
BioPharma Dive
Thu, 03/9/23 - 09:15 pm
Tags:
Sandoz, Novartis, drug manufacturing, Slovenia, biosimilars
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Tue, 02/7/23 - 12:22 pm
Tags:
Sandoz, Novartis, biosimilars, osteoporosis, Prolia, Xgeva, FDA
Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
Yahoo/Benzinga
Wed, 02/1/23 - 10:39 am
Tags:
Novartis, earnings, Sandoz
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Wed, 01/25/23 - 10:44 am
Tags:
Sandoz, Novartis, Astellas, antifungals, Mycamine, generics
JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says
Fierce Pharma
Mon, 01/9/23 - 10:43 pm
Tags:
Novartis, JPMHC 2023, Sandoz, Respiratory, eye health
As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader
Fierce Pharma
Mon, 11/21/22 - 10:30 am
Tags:
Pharma CEOs, Teva Pharmaceutical, Kåre Schultz, Richard Francis, Sandoz
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
Endpoints
Mon, 10/31/22 - 04:22 pm
Tags:
AbbVie, Orilissa, generics, Sandoz, Teva Pharmaceuticals, endometriosis
Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
Fri, 10/7/22 - 10:50 am
Tags:
ADHD, Adderall, drug shortages, Sandoz, Sun Pharma, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.